COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...
Q4 2025 Earnings Call Transcript November 25, 2025 Embecta Corp. misses on earnings expectations. Reported EPS is $ EPS, ...
Q3 2025 Earnings Call Transcript November 25, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...
Q3 2025 Earnings Call November 26, 2025 9:00 AM ESTCompany ParticipantsBabak Pedram - Chief Operating OfficerAdam Adamou ...
Q3 2025 Earnings Call November 26, 2025 9:00 AM ESTCompany ParticipantsAna Bartesaghi - Chief Investor Relations ...
This press release may not be distributed directly or indirectly in the United States, Canada, United Kingdom, Australia or Japan. Success of a fundraising consisting of a reserved offering to local ...
The Fundraising, in a gross amount of €105,000,000.54, and the Reserved Capital Increase, in an amount of €39,262,015.44, have resulted in the issuance of an aggregate of 141,433,349 new ordinary ...
We all know about profit and loss for retailers. If you’ve ever stayed up until midnight on Thanksgiving in order to be among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback